Nationwide Fund Advisors decreased its position in Clorox Company (The) (NYSE:CLX) by 0.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,965 shares of the company’s stock after selling 299 shares during the quarter. Nationwide Fund Advisors’ holdings in Clorox Company (The) were worth $4,792,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Synovus Financial Corp grew its position in Clorox Company (The) by 14.5% during the second quarter. Synovus Financial Corp now owns 8,786 shares of the company’s stock valued at $1,173,000 after buying an additional 1,114 shares during the period. OMERS ADMINISTRATION Corp bought a new position in Clorox Company (The) during the second quarter valued at about $2,184,000. Geode Capital Management LLC grew its position in Clorox Company (The) by 4.3% during the first quarter. Geode Capital Management LLC now owns 1,247,940 shares of the company’s stock valued at $168,019,000 after buying an additional 51,563 shares during the period. IMS Capital Management bought a new position in Clorox Company (The) during the second quarter valued at about $168,000. Finally, Great Lakes Advisors LLC grew its position in Clorox Company (The) by 3.3% during the second quarter. Great Lakes Advisors LLC now owns 5,970 shares of the company’s stock valued at $795,000 after buying an additional 192 shares during the period. Hedge funds and other institutional investors own 71.33% of the company’s stock.

Several equities analysts recently weighed in on CLX shares. BMO Capital Markets restated an “outperform” rating on shares of Clorox Company (The) in a research report on Tuesday, September 12th. BidaskClub lowered shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a research report on Wednesday, July 5th. Deutsche Bank AG restated a “hold” rating and set a $137.00 price target (up previously from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. Royal Bank Of Canada restated a “hold” rating and set a $115.00 price target on shares of Clorox Company (The) in a research report on Friday, June 30th. Finally, Zacks Investment Research upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price target for the company in a research report on Tuesday, July 4th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the stock. Clorox Company (The) has an average rating of “Hold” and a consensus price target of $127.39.

In other news, EVP James E. Foster sold 9,861 shares of Clorox Company (The) stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the transaction, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Jon M. Balousek sold 9,223 shares of Clorox Company (The) stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the transaction, the senior vice president now directly owns 20,614 shares in the company, valued at $2,862,666.18. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 21,242 shares of company stock worth $2,944,449. Insiders own 1.00% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Clorox Company (The) (CLX) Stake Lessened by Nationwide Fund Advisors” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another site, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/10/07/clorox-company-the-clx-stake-lessened-by-nationwide-fund-advisors.html.

Shares of Clorox Company (NYSE:CLX) opened at 129.14 on Friday. The firm’s 50-day moving average is $134.59 and its 200 day moving average is $134.61. The stock has a market capitalization of $16.67 billion, a P/E ratio of 24.21 and a beta of 0.39. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. During the same period in the previous year, the firm earned $1.30 EPS. The business’s quarterly revenue was up 2.9% on a year-over-year basis. On average, equities research analysts forecast that Clorox Company will post $5.66 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 13th. Stockholders of record on Wednesday, October 25th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, October 24th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.60%. Clorox Company (The)’s payout ratio is currently 63.04%.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.